Vitamin A Metabolism, Assessment, and Supplementation Guidelines

1. Metabolic Overview

• Vitamin A metabolism comprises intestinal absorption of dietary retinoids and provitamin A carotenoids, hepatic storage as retinyl esters, regulated release bound to retinol‑binding protein (RBP) coupled to transthyretin, and tissue‑specific conversion to retinal (vision) and all‑trans‑retinoic acid (gene regulation)【1】.

2. Intestinal Absorption

• Provitamin A carotenoids (β‑carotene, α‑carotene, cryptoxanthin) require enzymatic conversion to retinol before utilization【2】.
• The bioconversion efficiency of provitamin A carotenoids ranges from 3.6 : 1 to 28 : 1, meaning substantially more carotenoid is needed compared with preformed retinol【2】.
• At physiological doses, retinol uptake occurs via a saturable carrier‑mediated transporter; at pharmacological doses the process shifts to passive diffusion【1】.
• Overall retinoid absorption efficiency is high (≈ 75‑100 %); carotenoid absorption is highly variable and depends on the food matrix and carotenoid type【1】.
• Fat‑soluble vitamins, including vitamin A, are absorbed primarily in the upper small intestine【1】.

3. Hepatic Storage and Circulatory Transport

• Approximately 90 % or more of total body vitamin A is stored in the liver as retinyl esters【1】.
• Mobilized vitamin A is transported in plasma as retinol bound to RBP, which is complexed with transthyretin (pre‑albumin)【2】【1】.
• RBP behaves as a negative acute‑phase protein; its concentration declines during inflammation independent of true vitamin A status【1】.

4. Conversion to Active Metabolites and Gene Regulation

• All‑trans‑retinoic acid functions as a pro‑hormone and is the primary physiologically active form that regulates gene expression【1】.
• Both all‑trans‑retinoic acid and 9‑cis‑retinoic acid serve as ligands for nuclear receptors (RAR and RXR)【1】.
• Retinoic acid binds to RAR and RXR families; these receptors form heterodimers with each other and with other nuclear receptors (e.g., vitamin D, steroid/thyroid hormone receptors)【1】.
• Activated RAR/RXR complexes regulate > 500 target genes involved in cellular growth, differentiation, immune function, reproduction, and development【2】【1】.

5. Regulation, Risk Factors, and Clinical Consequences

• Provitamin A carotenoids (β‑carotene) are subject to negative feedback control, making them safer than preformed retinol because they cannot cause toxicity【3】【4】.
• Zinc deficiency impairs hepatic RBP synthesis and hampers vitamin A mobilization from liver stores【2】.
• Vitamin A deficiency compromises epithelial cell differentiation, mucous membrane integrity, T‑cell–mediated immunity, and growth/development in children【2】.
• In cystic fibrosis, deficiency is linked to poorer clinical status, reduced lung function, and increased pulmonary exacerbations【3】【4】.
• High‑risk conditions for deficiency include severe infection (e.g., sepsis, HIV), burns, mechanical ventilation, chronic steroid use, hepatobiliary or renal dysfunction, major trauma, hematologic/oncologic disease, intestinal malabsorption, protein‑energy malnutrition, zinc deficiency, and cystic fibrosis【2】.

6. Clinical Assessment

7. Supplementation Recommendations

7.1 Pediatric Parenteral Nutrition

• Preterm infants: 700‑1500 IU/kg/day (≈ 227‑455 µg/kg/day)【5】【2】.
• Term infants: 150‑300 µg/kg/day (≈ 2300 IU/day)【5】【2】.
• Older children: 150 µg/day【5】【2】.
• Administration: Lipid‑soluble vitamin A should be mixed with a lipid emulsion; water‑soluble solutions cause > 60 % loss【5】【2】.

7.2 Cystic Fibrosis (Special Population)

• Initiate low‑dose preformed vitamin A; titrate to achieve normal serum reference range【3】【4】.
• Beta‑carotene (provitamin A) dosing: 1 mg/kg/day (max 50 mg/day) for 12 weeks, then maintenance ≤ 10 mg/day; monitor serum levels; beta‑carotene is safer due to negative feedback control【3】【4】.

7.3 Practical Pitfalls (Applicable to All Patients)

• Do not use water‑based parenteral vitamin A solutions – employ lipid emulsions to avoid > 60 % drug loss【5】【2】.
• Do not rely on serum retinol during acute illness or inflammation; prefer RBP/transthyretin ratio or defer testing【2】.
• Do not overlook dietary sources when prescribing supplements, as they influence total intake and toxicity risk【3】【4】.
• Do not assess vitamin A status in patients with zinc or protein deficiency without accounting for their confounding effect on RBP and serum retinol【2】.

All facts are derived from peer‑reviewed clinical nutrition sources; the strength of evidence is not explicitly graded in the source material.

Vitamin A Deficiency Diagnosis and Monitoring

Primary Diagnostic Tests

• The American College of Nutrition recommends serum retinol measured by high-pressure liquid chromatography (HPLC) as the primary laboratory test to confirm vitamin A deficiency, with levels below 0.7 mmol/L indicating deficiency in adults and children over 6 months 6, 7
• Normal range for serum retinol is 1.05–2.8 mmol/L for children >6 months and adults, as stated by the Clinical Nutrition society 6, 8
• Deficiency thresholds are: <0.7 mmol/L for deficiency and <0.35 mmol/L for severe deficiency with depleted liver stores, according to the Clinical Nutrition guidelines 6, 8
• Serum retinol remains homeostatically controlled until liver stores are severely depleted, making it insensitive for detecting early deficiency, as noted by the Clinical Nutrition society 7
• Retinol-Binding Protein (RBP) <0.48 mmol/L is associated with severe vitamin A deficiency, as stated by the Clinical Nutrition society 6, 8

Functional Assessment Tests

• The Relative Dose Response (RDR) test involves administering 450–1000 μg retinyl palmitate orally and measuring serum retinol at baseline and 5 hours post-dose, with an RDR ≥14–20% indicating deficiency and depleted liver stores, as recommended by the Clinical Nutrition society 6, 7, 9
• The RDR test is considered valid for determining inadequate vitamin A status as it indirectly measures hepatic retinol stores, according to the Clinical Nutrition society 7, 9

Special Considerations for Inflammation

• Serum retinol and RBP concentrations decrease with increasing inflammation, independent of true vitamin A status, as noted by the Clinical Nutrition society 7, 9
• During inflammation, RBP release from the liver is reduced and the prealbumin-RBP complex redistributes from plasma, according to the Clinical Nutrition society 7, 9
• Measure C-reactive protein (CRP) and/or alpha-1-acid glycoprotein (AGP) simultaneously to adjust for inflammation, as recommended by the Clinical Nutrition society 7, 9

High-Risk Populations Requiring Testing

• Check vitamin A levels in patients with night blindness, xerophthalmia, Bitot spots, or other ocular symptoms, as recommended by the Clinical Nutrition society and Praxis Medical Insights 6, 7, 10, 11
• Patients with chronic liver disease, malabsorptive procedures, steatorrhea, protein malnutrition, chronic conditions, and chronic kidney disease require regular monitoring, as stated by the Clinical Nutrition society and Praxis Medical Insights 6, 7, 10, 12

Monitoring Frequency

• Initial assessment: 3, 6, and 12 months post-bariatric surgery or in high-risk conditions, as recommended by the Obesity Reviews society 12
• Ongoing: At least annually thereafter, according to the Obesity Reviews society 12

Important Pitfalls

• Serum retinol can remain falsely normal despite depleted liver stores, particularly in chronic alcohol consumption, as noted by Praxis Medical Insights 10
• Zinc and protein deficiencies can confound serum retinol measurements, according to the Clinical Nutrition society 7, 9
• Retinoids are susceptible to photo-degradation and oxidation; samples require antioxidants, light protection, and proper temperature handling, as recommended by the Clinical Nutrition society 7, 9
• Retinyl esters >250 nmol/L in serum suggest hypervitaminosis A, not deficiency, as stated by the Clinical Nutrition society 7, 9